Monogram Technologies (MGRM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2024 Annual Meeting will be held virtually on December 19, 2024, with voting on four key proposals and other business as may arise.
Stockholders of record as of October 25, 2024, are eligible to vote, with each share of common stock entitled to one vote; cumulative voting is not permitted.
Proxy materials are primarily distributed electronically to reduce costs and environmental impact, with options for mail or email delivery upon request.
Voting matters and shareholder proposals
Proposal 1: Election of two Class I directors (Rick Van Kirk and Colleen Gray) to serve until the 2027 annual meeting.
Proposal 2: Ratification of Fruci & Associates II, PLLC as the independent registered public accounting firm for 2024.
Proposal 3: Approval of an amendment to the 2019 Stock Option and Grant Plan, increasing available shares and adding an evergreen provision.
Proposal 4: Advisory vote on executive compensation (say-on-pay).
The board recommends voting FOR all proposals.
Board of directors and corporate governance
The board consists of five directors, divided into three classes, with a majority being independent under Nasdaq rules.
Committees include Audit, Compensation, and Nomination, each chaired by Paul Riss and composed of independent directors.
The board regularly reviews its leadership structure and risk oversight, with the Chairman and CEO roles currently separated.
Directors are encouraged to attend annual meetings, and independent directors meet in executive sessions.
A code of business conduct and ethics applies to all employees, officers, and directors.
Latest events from Monogram Technologies
- Autonomous robotic cutting technology targets a major shift in orthopedic surgery standards.MGRM
17th Annual LD Micro Main Event Conference17 Jan 2026 - $16.6M cash, $12.1M net loss YTD, FDA progress, and India trial set stage for 2025–2026 launch.MGRM
Q3 202413 Jan 2026 - Strong cash, regulatory progress, and technical milestones drive robotic knee launch outlook.MGRM
Q4 202426 Dec 2025 - AI-driven orthopedic robotics firm files to offer up to $100M in flexible securities for growth.MGRM
Registration Filing16 Dec 2025 - Stockholders to vote on merger offering $4.04 cash plus CVR per share; board recommends approval.MGRM
Proxy Filing2 Dec 2025 - Zimmer Biomet to acquire Monogram for $4.04/share plus CVR; milestone payouts up to $12.37/share.MGRM
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor, stock plan amendment, and executive pay.MGRM
Proxy Filing2 Dec 2025 - Stockholders to vote on merger with Zimmer Biomet, receiving $4.04 cash plus CVR per share.MGRM
Proxy Filing2 Dec 2025 - Merger vote set: $4.04/share cash plus CVR; board and major holders back Zimmer Biomet deal.MGRM
Proxy Filing2 Dec 2025